Hidden Hunger: Study Highlights Commonly Missing Micronutrients in People with Type 2 Diabetes Dr. Bhumika Maikhuri31 Jan 2025 3:00 AMMicronutrient deficiency, whereby levels of vitamins and minerals essential for healthy bodily function are far too low, is common in people with type...
FDA approves Semaglutide for renal protection among diabetes patients with CKD Dr. Kamal Kant Kohli30 Jan 2025 3:30 AMNovo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk of worsening kidney...
Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease Ruchika Sharma29 Jan 2025 8:00 AMPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...
Lignan Intake Linked to Lower Mortality in Individuals with Type 2 Diabetes: Study Dr Riya Dave29 Jan 2025 3:30 AMResearchers have demonstrated in a new study that higher levels of lignan consumption may lower the risk of mortality in a patient with type 2...
Lack of essential vitamins and minerals common in people with type 2 diabetes, reveals research Dr. Kamal Kant Kohli29 Jan 2025 12:30 AMMicronutrient deficiency, whereby levels of vitamins and minerals essential for healthy bodily function are far too low, is common in people with type...
Novel Obesity Drug Induces Weight Loss Up to 22% with No Safety Concerns in clinical trial Dr. Kamal Kant Kohli27 Jan 2025 4:30 AMIn a phase 1b/2a trial subcutaneous amycretin demonstrated a safety profile similar to other incretin-based drugs . Adults with obesity experienced...
Comparative Effectiveness of SGLT-2 Inhibitors: Low-Dose Dapagliflozin Falls Short in Heart Failure Prevention, Study Medha Baranwal24 Jan 2025 3:30 AMUSA: A recent study published in JAMA Internal Medicine has evaluated the comparative effectiveness of individual sodium-glucose cotransporter 2...
Empagliflozin and dapagliflozin have comparable long-term kidney outcomes in Type 2 Diabetes: JAMA Dr. Shravani Dali24 Jan 2025 3:30 AMThe results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or dapagliflozin had...
SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission: Study Dr. Kamal Kant Kohli23 Jan 2025 3:45 AMAdults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside...
Type 2 Diabetes Linked to Increased Asthma Risk, Regardless of Genetic Susceptibility: Longitudinal Study Finds Medha Baranwal23 Jan 2025 3:30 AMChina: A recent longitudinal study published in BMC Public Health has shed light on a significant association between type 2 diabetes (T2D) and the...
Medical Bulletin 20/ January/ 2025 Dr. Bhumika Maikhuri20 Jan 2025 9:30 AMHere are the top medical news for the day:Genetics and Environmental Factors Contributing to Childhood Obesity: Study FindsA cutting-edge molecular...
Gestational Diabetes Linked to Type 2 Diabetes, but Causes Vary by Individual: Study Finds Dr. Bhumika Maikhuri20 Jan 2025 3:15 AMWomen who have gestational diabetes have increased risk of type 2 diabetes in the years after delivery. Those who go on to develop the chronic disease...
